Advertisement
Advertisement
U.S. Markets open in 2 hrs 28 mins
Advertisement
Advertisement
Advertisement
Advertisement

Collegium Pharmaceutical, Inc. (COLL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.05-0.48 (-2.90%)
At close: 04:00PM EDT
16.05 0.00 (0.00%)
After hours: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close16.53
Open16.43
Bid0.00 x 800
Ask0.00 x 900
Day's Range15.88 - 16.45
52 Week Range14.04 - 22.89
Volume249,578
Avg. Volume250,577
Market Cap561.891M
Beta (5Y Monthly)0.94
PE Ratio (TTM)21.12
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Collegium Announces 11 Poster Presentations at PAINWeek 2022 National Conference

    STOUGHTON, Mass., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that 11 poster presentations highlighting data regarding its product portfolio will be presented at the Annual PAINWeek National Conference, taking place September 6-9, 2022 in Las Vegas, NV. “Collegium is excited to support 11 posters regarding our meaningfully differentiated product portfolio that will be presented at PAINWe

  • GlobeNewswire

    Collegium Reports Second Quarter 2022 Financial Results

    – Generated Record Net Revenue of $123.5 Million – – BDSI Integration Complete; On Track to Exceed Targeted Run Rate Synergies of at Least $75 Million – – Raises Full Year Adjusted EBITDA Guidance – – Conference Call Scheduled for Today at 4:30 p.m. ET – STOUGHTON, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today reported its financial results for the quarter ended June 30, 2022 and provided a c

  • GlobeNewswire

    Collegium to Report Second Quarter 2022 Financial Results on August 4, 2022

    STOUGHTON, Mass., July 21, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that it will report second quarter 2022 financial results after the market closes on Thursday, August 4, 2022. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET. Conference Call Information To access the conference call, please dial (877) 407-8037 (U.S.) or (201)

Advertisement
Advertisement